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[Introduction] Acute cholangitis and cholecystitis (AC) progresses from local biliary infection 
to systemic inflammatory response syndrome (SIRS), because of spillage of pathogens or 
pathogen associated molecules. Advanced disease then leads to sepsis with or without 
disseminated intravascular coagulation (DIC) and organ dysfunction. Endotoxemia is often 
observed when AC progresses to a severe pathological condition of sepsis (Shimada H, et al., 
1984). For the measurement of endotoxin in blood, a turbidimetric assay using Limulus 
Amebocyte Lysate (LAL assay) has been widely used. However, the usefulness of this assay in 
biological samples is limited (Marshall JC, et al., 2004). Recently, another method for rapid 
measurement of blood endotoxin levels within 2 h, the Endotoxin Activity Assay (EAA), was 
developed, and its usefulness is widely accepted (Valenza F et al., 2009; Yoneyama H, et al., 
2010; Pathan N, et al., 2010). In this study, we measured EAA levels in patients with biliary 
tract infection at the early stage of disease progression. We also examined the relevance of 
EAA levels for magnitude of activated neutrophils by endotoxin and evaluated its usefulness 
as a prediction marker of disease severity.  
[Methods] We retrospectively reviewed 98 collected consecutive cases of acute biliary tract 
infection who were admitted between June 2011 and August 2012. They also fulfilled at least 
two of the diagnostic criteria for systemic inflammatory response syndrome (SIRS) on 
admission. Patients’ clinical and microbiological data and blood examination data were 
prospectively collected. We examined the baseline characteristics of age, sex, white blood cell 
count, C-reactive protein levels, procalcitonin levels, endotoxin levels measured by the LAL 
assay, EAA levels, and bacterial culture of blood and bile samples on admission. At the time of 
the EAA, blood samples were drawn and whole blood was sent for blood culture. For analysis, 
laboratory data were used from the time point closest to when the EAA was performed. The 
Japanese Association for Acute Medicine DIC score and the sequential organ failure 
assessment score (SOFA score) were recorded within 24 h after admission.  
[Results] Endotoxin levels measured by the LAL assay were mostly below the detection limit 
and there was no correlation with EAA levels . Blood culture was done in the samples from all 
the patients.The positive culture rate of blood was 28% in all patients. The percentage of 
distribution of bacterial organisms was 20% for Gram-negative organisms and 8% for 
Gram-positive organisms. The positive culture rate of blood was significantly higher in over 
points 0.4 group than under points 0.4 group. Patients were then stratified according to their 
EAA results into the following groups: the low (L) group (EAA levels <0.4) and the high (H) 
group (EAA levels ≥0.4).  
The WBC count was not significantly different between the two groups. CRP and PCT levels 
were increased in the H group compared with the L group. There were no significant 
differences in the prothrombin time international normalized ratio and fibrin and fibrinogen 
degradation products between the two groups. However, platelet counts were significantly 
lower in the H group than in the L group. The ratio of patients with a JAAM DIC score of ≥4 
was significantly higher and the duration of DIC was significantly longer in the H group than 
in the L group. The ratio of patients with an SOFA score of ≥5 was significantly higher and 
hospital stay was significantly longer in the H group than in the L group. The percentage of 
patients with a JAAM DIC score of≥4 (62% vs.9%, p<0.001) was significantly higher, the 
percentage of patients with an SOFA score of ≥5 (p<0.001) was significantly higher, and 
hospital stay (p=0.003) was significantly longer in patients with a severe grade of AC than in 
patients with a mild or moderate grade. The ratio of patients with EAA levels ≥0.4 in the 
severe grade of the JGL was significantly higher than that in patients with a mild or 
moderate grade (32% vs. 15%, p=0.05). The positive culture rate of blood was higher in 
patients with a severe grade than in patients with a mild or moderate grade (57% vs. 19%, 
p=0.001).  
[Discussion] The LAL assay is widely used for measurement of endotoxin in blood. Blood 
culture is also used for the detection of bacteremia, but the results of a positive culture rate 
are not usually high. Additionally, both methods require time to obtain results, and their 
clinical usefulness is limited because of low sensitivity and possible false positive results. The 
EAA has been developed and used as an alternative to the LAL assay (Romaschin A, et al., 
1998). In our study, the EAA is practical for evaluating biliary tract infection. The EAA levels 
reflect blood infection and magnitude of activated neutrophils by endotoxin, as well as the 
severity of AC. On the other hand, several patients with low EAA levels (<0.4) showed positive 
results in blood culture. Most of those cases were categorized as a mild or moderate grade of 
severity. Rapid and precise assessment of disease severity is critically important for the 
improvement of patient outcomes of AC. The combination of the EAA levels and other 
biomarkers may improve the performance of disease severity prediction. We also show that 
EAA levels may be a useful marker for that purpose. 
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